WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005011698) COMBINATION COMPRISING A LIPOSOME-ENCAPSULATED VINCA ALKALOID AND A TOPOISOMERASE II INHIBITOR AND THE USE THEREOF FOR TREATING NEOPLASIA
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/011698    International Application No.:    PCT/CA2004/001038
Publication Date: 10.02.2005 International Filing Date: 23.07.2004
IPC:
A61K 9/127 (2006.01), A61K 31/475 (2006.01), A61K 31/704 (2006.01), A61K 45/06 (2006.01)
Applicants: INEX PHARMACEUTICALS CORPORATION [CA/CA]; 100-8900 Glenlyon Parkway, Glenlyon Business Park, Burnaby, British Columbia V5J 5J8 (CA) (For All Designated States Except US).
SALTMAN, David [CA/CA]; (CA) (For US Only)
Inventors: SALTMAN, David; (CA)
Agent: LONG, J., Erin; Inex Pharmaceuticals Corporation, 100-8900 Glenlyon Parkway, Glenlyon Business Park, Burnaby, British Columbia V5J 5J8 (CA)
Priority Data:
60/490,789 28.07.2003 US
Title (EN) COMBINATION COMPRISING A LIPOSOME-ENCAPSULATED VINCA ALKALOID AND A TOPOISOMERASE II INHIBITOR AND THE USE THEREOF FOR TREATING NEOPLASIA
(FR) COMBINAISON COMPORTANT UN ALCALOIDE DE PERVENCHE ENCAPSULES DANS UN LIPOSOME ET UN INHIBITEUR DE TOPOISOMERASE II, ET UTILISATION DE CETTE COMBINAISON POUR LE TRAITEMENT DES NEOPLASIES
Abstract: front page image
(EN)This invention provides methods for treating neoplasias in a mammal. In particular, the invention provides methods for treating various types of lymphomas, including relapsed forms of non-Hodgkin’s Lymphoma. These methods involve the co-administration of liposome-encapsulated vinca alkaloids, e.g., vincristine, with a topoisomerase II inhibitor, e.g., etoposide or NK-611, to a mammal with a lymphoma or a sarcoma.
(FR)L'invention se rapporte à des méthodes de traitement des néoplasies chez des sujets mammifères. En particulier, l'invention se rapporte à des méthodes de traitement de divers types de lymphomes, notamment de formes récidivantes du lymphome non hodgkinien. Ces méthodes consistent en une co-administration d'alcaloïdes de la pervenche encapsulés dans des liposomes, par exemple, de la vincristine, et d'un inhibiteur de topoisomérase II, par exemple, de l'étoposide ou NA-611, à un mammifère présentant un lymphome ou un sarcome.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)